Interaction with human immunodeficiency virus (HIV) type 2 predicts HIV type 1 genotype

Virology

Volumn 268, Issue 2, 2000, Pages 402-410

  Sarr, Abdoulaye Dieng ^a   Sankalé, Jean Louis ^a   Hamel, Donald J ^a   Travers, Karin U ^a   Guèye Ndiaye, Aissatou ^b   Essex, Max ^a   Mboup, Souleymane ^b   Kanki, Phyllis J ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITÉ CHEIKH ANTA DIOP   (Senegal)

Author keywords

Dual infection; HIV 1; HIV 2; Subtypes; West Africa

Indexed keywords

ENVELOPE PROTEIN;

ARTICLE; CLINICAL ARTICLE; FEMALE; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MIXED INFECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PREDICTION; PRIORITY JOURNAL; VIRUS TYPING;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; RNA VIRUSES;

EID: 0034654376     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.2000.0192     Document Type: Article

References (50)

1. Akimoto H., Kaneko H., Sekigawa I., Kaneko Y., Yamamto N. Binding of HIV-2 envelope glycoprotein to CD8 molecules and related chemokines production. Immunology. 95:1998;214-218.
2. Ariyoshi K., Cham F., Berry N., Harding E., Sabally R., Ngom P. T., Ishikawa K, Corrah T., Tedder R., Whittle H. Diagnostic of HIV-1 and HIV-2 dual infection using dilution analysis of type specific antibody. AIDS. 12:1998;2504-2505.
3. Arya S., Gallo R. C. Human immunodeficiency virus (HIV) type 2 mediated inhibition of HIV type 1: A new approach to gene therapy of HIV infection. Proc. Natl. Acad. Sci. USA. 93:1996;4486-4491.
4. Asjo B., Barin F., Biberfeld G., Bradac J., Buve A., Fontanet A., Gurtler L., Van-der Groen G. HIV-1 subtypes: Implication for epidemiology, pathogenicity, vaccines and diagnosis: Workshop report from the European Commission and UNAIDS. AIDS. 1997:1997;A17-A36.
5. Bhattacharyya D., Brooks B., Callahan L. Positioning of positively charged residues in the V3 loop correlates with HIV-1 syncytium-inducing phenotype. AIDS Res. Hum. Retroviruses. 12:1996;83-90.
6. Burke D. S., McCutchan F. E. Global distribution of human immunodeficiency virus-1 clades. Vincent J., DeVita T., Hellman S., Rosenberg S. A. AIDS: Biology, Diagnosis, Treatment and Prevention. 1997;119-126 Lippincott-Raven Publishers, Philadelphia.
7. Carr J. K., Laukkanen T., Salminen M. O., Albert J., Alaeus A., Kim B., Sanders-Buell E., Birx D. L., McCutchan F. E. Characterization of subtype A HIV-1 from Africa by full genome sequencing. AIDS. 13:1999;1819-1826.
8. Chen Z., Luckay A., Sodora D. L., Telfer P., Reed P., Gettie A., Kanu J. M., Sadek R. F., Yee J., Ho D. D., Zhang L., Marx P. A. Human immunodeficiency virus type 2 (HIV-2) seroprevalence and characterization of a distinct HIV-2 genetic subtype from the natural range of simian immunodeficiency virus infected sooty mangabeys. J. Virol. 71:1997;3953-3960.
9. Cornelisen M., Kampinga G., Zorgdrager F., Goudsmit J. Human immunodeficiency type 1 subtypes defined by env show high frequency of recombinant gag genes. J. Virol. 70:1996;8209-8212.
10. de Wolf F., Hogervorst E., Goudsmit J., Fenyo E. M., Rubsamen-Waigmann H., Holmes H., Galvao-Castro B., Karita E., Wasi C., Sempala S. D. Syncytium-inducing and non-syncytium-inducing capacity of human immunodeficiency virus type I subtypes other than B: Phenotypic and genotypic characteristics. AIDS Res. Hum. Retroviruses. 10:1994;1387-1400.
11. + lymphocyte counts. AIDS. 12:1998;131-137.
12. + lymphocyte count differs in monotypic and dual HIV infections. J. Hum. Virol. 2:1999;45-51.
13. Dieng Sarr A., Sankalé J. L., Gueye-Ndiaye A., Essex M., Mboup S., Kanki P. genetic characterization of human immunodeficiency virus type 2 in monotypic, and dual HIV infections. AIDS Res. Hum. Retroviruses. 2000.
14. Fouchier R., Groenink M., Kootstra N., Tersmette M. Phenotypes associated sequence variation in the third variable region of the human immunodeficiency virus type 1 gp 120. J. Virol. 66:1992;3183-3187.
15. Gao F., Yue L., Robertson D. L., Hill S. C., Hui H., Biggar R. J., Neequaye A. E., Whelan T. M., Ho D. D., Shaw G. M., Sharp P. M., Hahn B. H. Genetic diversity of human immunodeficiency virus type 2: Evidence for distinct sequence subtypes with differences in virus biology. J. Virol. 68:1994;7433-7447.
16. Gueye-Ndiaye A., Clark R., Samuel K., Ndour-Sarr A. N., Ouangre A., Sangare L., Mboup S., Marlink R., Papas T., Child R., Coll-Seck A., Essex M., Kanki P. Cost-effective diagnosis of HIV-1 and HIV-2 by recombinant-expressed env peptide (566/966) dot blot analysis. AIDS. 7:1993;481-495.
17. Gurtler L. G., Zekeng L., Tsague J. M., van Brunn A., Eberle J., Kaptue L. HIV-1 subtype O: Epidemiology, pathogenesis, diagnosis, and perspectives of the evolution of HIV. Arch. Virol. Suppl. 11:1996;195-202.
18. Harmelen J., Wood R., Lambrick M., Rybicki E., Williamson A., Williamson C. An association between HIV-1 subtypes and mode of transmission in Cape Town, South Africa. AIDS. 11:1997;81-87.
19. Heredia A., Vallejo A., Soriano V., Guteirrez M., Aguilera A., Epstein J. S., Mas A., Hewlett I K. Evidence of HIV-2 infection in equatorial Guinea (Central Africa): Partial genetic analysis of a B subtype virus. AIDS Res. Hum. Retroviruses. 13:1997;439-440.
20. Janssens W., Buve A., Nkengasong J. The puzzle of HIV-1 subtypes in Africa. AIDS. 11:1997;705-712.
21. Kaneko H., Neoh L., Takeda N., Akimoto H., Hishikawa T., Hashimoto H., Hirose S., Karaki S., Takiguchi M., Nakauchi H., Kaneko Y., Yamamoto N., Sekigawa I. Human immunodeficiency virus type 2 envelope glycoprotein binds to CD8 as well as CD4 molecules on human T cells. J. Virol. 71:1997;8918-8922.
22. Kanki P. Epidemiology and natural history of HIV-2. DeVita V. J., Hellman S., Rosenberg S. In AIDS: Etiology, Diagnosis, Treatment, and Prevention. 1997;127-135 J. B. Lippincott Co. Philadelphia.
23. Kanki P., Travers K., Hernandez-Avila M., Marlink R., Mboup S., Gueye-Ndiaye A., Siby T., Thior I., Sankalé J. L., Ndoye I., Hsieh C. C., Essex M. Slower heterosexual spread of HIV-2 compared with HIV-1. Lancet. 343:1994;943-946.
24. Kanki P. J., Hamel D. J., Sankale J. L., Hsieh C., Thior I., Barin F., Woodcock S. A., Gueye-Ndiaye A., Zhang E., Montano M., Siby T., Marlink R., Ndoye I., Essex M. E., Mboup S. Human immunodeficiency virus type 1 subtypes differ in disease progression. J. Infect. Dis. 179:1999;68-73.
25. Kokkotou, E. G, Sankale, J. L, Mani, I, Barin, F, Gueye-Ndiaye, A, Schwartz, D, Essex, M. E, Mboup, S, and, Kanki, P. J. 1999, In vitro correlates of HIV-2 mediated HIV-1 protection, submitted.
26. Laukkanen T., Albert J., Liitsola K., Green S., Carr J.-K., Leitner T., McCutchan F., Salminen M. Virtually full-length sequences of HIV-1 subtype J reference strains. AIDS Res. Hum. Retroviruses. 15:1999;293-297.
27. Louwagie J., Janssens W., Mascola J., Heyndrickx L., Hegerich P., Van Der Groen G., McCutchan F. E., Burke D. S. genetic diversity of the envelope glycoprotein from the human immunodeficiency virus type 1 isolates of African origin. J. Virol. 69:1995;263-272.
28. Martin R. A., Nayak D. P. Receptor interference mediated by the envelope glycoproteins of various HIV-1 and HIV-2 isolates. Virus Res. 45:1996;135-145.
29. McCutchan F. E., Carr J. K., Bajani M., Sanders-Buell E., Harry T. O., Stoeckli T. C., Robbins K. E., Gashau W., Nasidi A., Janssens W., Kalish M. L. Subtype G and multiple forms of A/G intersubtype recombinant human immunodeficiency virus type 1 in Nigeria. Virology. 254:1999;226-234.
30. Neilson J., John G., Carr J., Lewis P., Kreiss J., Jackson S., Nduati R., Mbori-Ngacha D., Panteleeff D. D., Bodrug. S., Giachetti C., Bott M., Richardson B. A., Bwayo J., Ndinya-Achiola D., Overbaugh J. Subtypes of human immunodeficiency virus type 1 and disease stage among women in Nairobi, Kenya. J. Virol. 73:1999;4393-4403.
31. Neoh L., Akimoto H., Kaneko H., Hishikawa T., Hashimoto H. Hirose, S. Kaneko Y., Yamamoto N., Sekigawa I. The production of betachemokines induced by HIV-2 envelope glycoprotein. AIDS. 11:1997;1062-1063.
32. Norrgren H., Marquina S., Leitner T., Aaby P., Melbye M., Poulsen A. G., Larsen O., Dias F., Escanilla D., Andersson S., Albert J., Naucler A. HIV-2 genetic variation and DNA load in asymptomatic carriers and AIDS cases in Guinea-Bissau. J. Acquir. Immune Defic. Syndr. 16:1997;31-38.
33. Peeters M., Koumare B., Mulanga C., Brengues C., Mounirou B., Bougoudogo F., Ravel S., Bibolletruche F., Delaporte E. Genetic subtypes of HIV type 1 and HIV type 2 strains in commercial sex workers from Bamako, Mali. AIDS Res. Hum. Retroviruses. 14:1998;51-58.
34. Peeters M., Vincent R., Perret J. L., Lasky M., Patrel D., Liegeois F., Courgnaud V., Seng R., Matton T., Molinier S., Delaporte E. Evidence for differences in MT2 cell tropism according to genetic subtypes of HIV-1: Syncytium-inducing variants seem rare among subtype C HIV-1 viruses. J. Acquir. Immune Defic. Syndr. 20:1999;115-121.
35. Plantier J.-C., Damond F., Lasky M., Sankale J.-L., Apetrei C., Peeters M., Buzelay S., Mboup S., Kanki P., Delaporte E., Simon F., Barin F. V3 serotyping of HIV-1 infection: Correlation with genotyping, limitation and identification of signature sequences. J. Acquir. Immune Defic. Syndr. 20:1999;432-441.
36. Robertson D. L., Hahn B. H., Sharp P. M. Recombination in AIDS viruses. J. Mol. Evol. 40:1995;249-259.
37. Robertson D. L., Sharp P. M., McCutchan F. E., Hahn B. H. Recombination in HIV-1 [letter]. Nature. 374:1995;124-126.
38. Sankalé J. L., de la Tour R. S., Renjifo B., Siby T., Mboup S., Marlink R. G., Essex M. E., Kanki P. J. Intrapatient variability of the human immunodeficiency virus type 2 envelope V3 loop. AIDS Res. Hum. Retroviruses. 11:1995;617-623.
39. Sankalé, J. L., Hamel, D., Traore, I., Dia, M. C., Gueye-Ndiaye, A., Essex, M. E., Mboup, S., and Kanki, P. J.1999. Molecular evolution of HIV-1 subtype A in Senegal: 1988-1997. Submitted.
40. Sekigawa I., Kaneko H., Neoh L., Takeda N., Akimoto H., Hishikawa T., Hashimoto H., Hirose S., Yamamoto N., Kaneko Y. Difference of HIV envelope glycoprotein between HIV-1 and HIV-2: Possible relation to lower virulence of HIV-2. Viral Immunol. 11:1998;1-8.
41. Siepel A.C, Halpern A. L., Macken C., Korber B. T. M. A computer program designed to rapidly screen for HIV-1 intersubtype recombinant sequences. AIDS Res. Hum. Retroviruses. 11:1995;1413-1425.
42. Shankarappa R., Gupta P., Learn G. H. Jr., Rodrigo A. G., Rinaldo C. R. Jr., Gorry M. C., Mullins J. I., Nara P. L., Ehrlich G. D. Evolution of human immunodeficiency virus type 1 envelope sequences in infected individuals with differing disease progression profiles. Virology. 241:1998;251-259.
43. Simon F., Mauclere P., Roques P., Loussert-Ajaka I., Muller-Trutwin M. C., Saragosti S., Georges-Courbot M. C., Barre-Sinoussi F., Brun-Vezinet F. Identification of a new human immunodeficiency virus type 1 distinct from group M and group O. Nat. Med. 4:1998;1030-1037.
44. Soto-Ramirez L., Renjifo B., McLane M. F., Marlink R., O'Hara C., Sutthent R., Wasi C., Vithayasai P., Vithayasai V., Apichartpiyakul C., Auewarakul P., Pena Cruz V., Chui D. S., Osathanondh R., Mayer K., Lee T. H., Essex M. HIV-1 Langerhan's cell tropism associated with heterosexual transmission of HIV. Science. 271:1996;1291-1293.
45. Takehisa J., Zekeng L., Miura T., Ido E., Yamashita M., Mboudjeka I., Gurtler L. G., Hayami M., Kaptue L. Triple HIV-1 infection with group O and group M of different clades in a single Cameroonian AIDS patient [letter]. J. Acquir. Immune Defic. Syndr. 14:1997;81-82.
46. Thompson J. D., Gibson T. J., Plewnisk f., Jeanmougin F., Higgins D. G. CLUSTAL X Windows interface: Flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res. 24:1997;4676-4882.
47. Travers K., Mboup S., Marlink R., Gueye-Ndiaye A., Siby T., Thior I., Traore I., Dieng-Sarr A., J. L. S., Mullins C., Ndoye I., Hsieh C. C., Essex M., Kanki P. Natural protection against HIV-1 infection provided by HIV-2. Science. 268:1995;1612-1615.
48. Tscherning C., Alaeus A., Fredriksson R., Bjorndal A., Deng H., Littman D. R., Fenyo E. M., Albert J. Differences in chemokine coreceptor usage between genetic subtypes of HIV-1. Virology. 241:1998;181-188.
49. Xiang Z., Ariyoshi K., Wilkins A., Dias F., Whittle H., Breuer J. HIV type 2 pathogenicity is not related to subtype in rural Guinea Bissau. AIDS Res. Hum. Retroviruses. 13:1997;501-505.
50. Xiao L., Owen S. M., Goldman I., Lal A. A., deJong J. J., Goudsmit J., Lal R. B. CCR5 coreceptor usage of non-syncytium-inducing primary HIV-1 is independent of phylogenetically distinct global HIV-1 isolates: Delineation of consensus motif in the V3 domain that predicts CCR-5 usage. Virology. 240:1998;83-92.